Filing Details
- Accession Number:
- 0001415889-24-004111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-16 16:15:31
- Reporting Period:
- 2024-02-14
- Accepted Time:
- 2024-02-16 16:15:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1672619 | Enliven Therapeutics Inc. | ELVN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598549 | J. Andrew Schwab | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | Yes | No | |
1664281 | Kush Parmar | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | Yes | No | |
1753000 | 5Am Opportunities I, L.p. | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | Yes | No | |
1753037 | 5Am Ventures Vi, L.p. | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | Yes | No | |
1790778 | 5Am Opportunities I (Gp), Llc | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | Yes | No | |
1829051 | 5Am Partners Vi, Llc | 501 2Nd Street, Suite 350 San Francisco CA 94107 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-14 | 688,358 | $14.90 | 3,200,634 | No | 4 | S | Indirect | By 5AMVentures VI, L.P. |
Common Stock | Disposition | 2024-02-14 | 136,642 | $14.90 | 635,341 | No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By 5AMVentures VI, L.P. |
No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.89 to $14.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
- The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein.